over other bDMARDs and tsDMARDs for patients with NTM lung disease who have moderate-tohigh disease activity despite csDMARDs Abatacept is conditionally recommended over other bD MARDs and tsDMARDs based on population data extrapolated from studies on tuberculosis The preceding 3 recommendations are conditional because of the very low-certainty evidence supporting the analysis of the differences in treatment outcomes posed by these PICO questions. DISCUSSION The ACR guidelines were developed to